文献速递瘢痕与激光美容整形

A型肉毒毒素预防病理性瘢痕的有效性与安全性:系统综述与荟萃分析

Efficacy and Safety of Botulinum Toxin Type A for Pathological Scar Prevention: A Systematic Review and Meta-Analysis.
PubMed 文献 · Plast Reconstr Surg · 2026-06-24

BoNT-A在温哥华瘢痕量表、视觉模拟量表、瘢痕宽度、Stony Brook瘢痕评估量表及患者与观察者瘢痕评估量表上均显示显著改善,患者满意度更高,不良反应轻微且短暂。结论认为BoNT-A有效且安全,但需更大样本和同质化设计的研究证实。

要点

  • BoNT-A可显著改善多项瘢痕评估指标并提高患者满意度。
  • 不良反应轻微且短暂,组间无显著差异。
  • 证据受限于样本量和研究异质性,需更高质量研究验证。

核心结论

  • BoNT-A是预防病理性瘢痕的有效且安全干预措施,可减少瘢痕形成并提高患者满意度,无严重不良反应。

主要发现

  • 温哥华瘢痕量表MD为-1.07(95%CI -1.59至-0.56;P<0.0001)。
  • 视觉模拟量表MD为1.18(95%CI 0.94至1.42;P<0.00001)。
  • 瘢痕宽度MD为-0.21(95%CI -0.33至-0.09;P=0.0008)。
  • Stony Brook瘢痕评估量表MD为1.64(95%CI 0.78至2.50;P=0.0002),患者与观察者瘢痕评估量表MD为-1.28(95%CI -2.02至-0.53;P=0.0008)。
  • 患者满意度RR为1.83(95%CI 1.10至3.07;P=0.02),不良反应轻微且短暂,组间无显著差异。

临床怎么用

  • 可考虑将BoNT-A用于病理性瘢痕的预防以改善瘢痕质量和患者满意度。

局限性

  • 研究样本量较小且设计异质性较大,需更大样本和同质化设计的研究确认结论。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The objective of this study was to evaluate the efficacy of botulinum toxin type A (BoNT-A) in preventing pathological scars and improving scar quality and to assess treatment safety and patient satisfaction. METHODS: Randomized controlled trials and cohort studies identified in PubMed, Scopus, Embase, or Web of Science were included. Outcomes analyzed included scar quality, patient satisfaction, and adverse effects. Statistical analysis was performed using mean differences (MDs) and relative risks (RRs). Risk of bias was assessed with the Risk of Bias 2 and Risk of Bias in Nonrandomized Studies of Interventions tools. RESULTS: Nineteen studies with a total of 686 patients were included. BoNT-A showed significant improvements in several outcomes. The MD was -1.07 (95% CI, -1.59 to -0.56; P < 0.0001) on the Vancouver Scar Scale and 1.18 (95% CI, 0.94 to 1.42; P < 0.00001) on the visual analog scale. Scar width was reduced, with an MD of -0.21 (95% CI, -0.33 to -0.09; P = 0.0008). In the Stony Brook Scar Evaluation Scale and Patient and Observer Scar Assessment Scale, the differences favored BoNT-A, with MD of 1.64 (95% CI, 0.78 to 2.50; P = 0.0002) and -1.28 (95% CI, -2.02 to -0.53; P = 0.0008), respectively. Patient satisfaction was higher with BoNT-A (RR, 1.83 [95% CI, 1.10 to 3.07]; P = 0.02). Adverse effects were minimal and transient, with no significant differences between groups. CONCLUSIONS: BoNT-A is an effective and safe intervention. Its use reduces the formation of pathological scars and generates high levels of patient satisfaction, without serious adverse effects. However, studies with larger sample sizes and homogeneous designs are required to confirm these findings.

来源:Plast Reconstr Surg,查看原文。版权归原作者所有。

引用

  1. Chávez-Goicochea AP, Lozano-Peralta K, Caballero-Alvarado J, et al. Efficacy and Safety of Botulinum Toxin Type A for Pathological Scar Prevention: A Systematic Review and Meta-Analysis. Plast Reconstr Surg. 2026. PMID: 42340826. doi:10.1097/PRS.0000000000012631

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。